Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Yi-Mi Wu(University of Michigan), Arul M. Chinnaiyan(University of Michigan), Moshe Talpaz(University of Michigan), Mark M. Zalupski(University of Michigan), Nickolay A. Khazanov(Howard Hughes Medical Institute), Felix Y. Feng(University of Michigan), Bushra Ateeq(Indian Institute of Technology Kanpur), Xuhong Cao(Howard Hughes Medical Institute), Su‐Fang Lin(National Health Research Institutes), Maha Hussain(Northwestern University), Seth Sadis(Howard Hughes Medical Institute), Pankaj Vats(University of Michigan), Fengyun Su(University of Michigan), Scott A. Tomlins(Stratasys (Israel)), Dan R. Robinson(University of Michigan), Ann‐Joy Cheng(Chang Gung University), Daniel R. Rhodes(Howard Hughes Medical Institute), Kenneth J. Pienta(Johns Hopkins University), Sameek Roychowdhury(The Ohio State University Wexner Medical Center), Shanker Kalyana‐Sundaram(University of Michigan), Rui Wang(Brigham and Women's Hospital), Lakshmi P. Kunju(University of Michigan), Robert J. Lonigro(University of Michigan), Javed Siddiqui(University of Michigan), Peter Wyngaard(Howard Hughes Medical Institute)
Cited by 737
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k